BridgeMD
New treatment option for Children With a Need of Rehabilitation for Handwriting
Official title Effects of the Use of an Immersive Virtual Reality Device on Handwriting in Children Aged 6 to 13 With Handwriting Difficulties ( RVALIGO )
ClinicalTrials.gov ID: NCT07040722
What this study is testing
- What it's testing
- Difficulties in learning to write affect a large number of children and can have a significant impact on their personal and professional future. To facilitate this learning process, develop fun, motivating and effective devices for the different skills involved in writing (motor skills, postural control, visual attention, letter recognition) is needing.
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 13
You may be able to join if
- Age : 6-13 years
- BHK: degradation score ≥ 1 standard deviation. The BHK will be administered at the time of the inclusion visit (V1) and/or child with writing...
- Children benefiting or to benefit from rehabilitation care to improve handwriting skills.
- Be able to understand instructions and complete all assessments.
You likely can't join if
- Contraindications to using a virtual reality HMD
- Severe visual impairment
- Facial injury
- Epilepsy
- Lack of parental and/or child consent
The study team makes the final eligibility decision.
Where it's taking place
- Pont-de-l'Arche, Eure, France
- Brest, Finistère, France
- Lesneven, Finistère, France
- Brest, France, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 13 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pont-de-l'Arche, Eure, France; Brest, Finistère, France; Lesneven, Finistère, France; Brest, France, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.